Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Jin-Kai Feng"'
Publikováno v:
Annals of Surgery Open, Vol 5, Iss 2, p e407 (2024)
Externí odkaz:
https://doaj.org/article/8dc4978d3296491a996c4ff7c300af07
Autor:
Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Jin-Kai Feng, Zong-Han Liu, Yun-Feng Shan, Yi-Tao Zheng, Qian-Zhi Ni, Shu-Qun Cheng
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background The use of Anti-PD-1 therapy has yielded promising outcomes in hepatocellular carcinoma (HCC). However, limited research has been conducted on the overall survival (OS) of patients with varying tumor responses and treatment durati
Externí odkaz:
https://doaj.org/article/28580eb814714c9bace2a2194c6774a8
Autor:
Hong-Fei Zhu, Jin-Kai Feng, Yan-Jun Xiang, Kang Wang, Li-Ping Zhou, Zong-Han Liu, Yu-Qiang Cheng, Jie Shi, Wei-Xing Guo, Shu-Qun Cheng
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of hepatocellular carcinoma (HCC). However, long-term survival outcomes and treatment response of HCC patients undergoing immunotherapy is unpredictable. The st
Externí odkaz:
https://doaj.org/article/3160f3deecbb447c921380c2af319223
Autor:
Wei‐Jun Wang, Zong‐Han Liu, Kang Wang, Hong‐Ming Yu, Yu‐Qiang Cheng, Yan‐Jun Xiang, Jin‐Kai Feng, Li‐Ping Zhou, Hong‐Kun Zhou, Wei‐Wei Pan, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11513-11524 (2023)
Abstract Background There is no consensus on the optimal regimen for unresectable recurrent hepatocellular carcinoma (HCC), so this retrospective study aimed to evaluate the efficacy and safety of transarterial chemoembolization (TACE) combined with
Externí odkaz:
https://doaj.org/article/6862c0cf51ad41c4a4df7fb2b3c55385
Autor:
Zong‐Han Liu, Zong‐Tao Chai, Jin‐Kai Feng, Yu‐Chao Hou, Xiu‐Ping Zhang, Zhen‐Hua Chen, Yan‐Jun Xiang, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10294-10302 (2023)
Abstract Background Early and late recurrence of hepatocellular carcinoma (HCC) have different clinical outcomes, especially for those accompanied by microvascular invasion (MVI), but the definition of early recurrence remains controversial. Therefor
Externí odkaz:
https://doaj.org/article/ecc77391e83c454b8fa8ab123bd7951a
Autor:
Yu Jiang Master of Engineering, Kang Wang Master of Medicine, Yu-Ran Wang Master of Engineering, Yan-Jun Xiang Master of Medicine, Zong-Han Liu Doctor of Medicine, Jin-Kai Feng Doctor of Medicine, Shu-Qun Cheng Doctor of Medicine
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Microvascular invasion of hepatocellular carcinoma is an important factor affecting tumor recurrence after liver resection and liver transplantation. There are many ways to classify microvascular invasion, however, an international consensus is urgen
Externí odkaz:
https://doaj.org/article/002b7237f3444673bdd0ff161cb088e0
Autor:
Min Zou, Yan-Sheng Zhang, Jin-Kai Feng, Hao Tu, Ming-Bin Gui, Ya-Nan Wang, Zi-Jie Yang, Zeng-Qiang Yang, Ming Xu, Wei-Qiang Wu, Feng Gao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveTo profile the serum metabolites and metabolic pathways in colorectal cancer (CRC) patients associated with spleen-deficiency and qi-stagnation syndrome (SDQSS) or damp-heat syndrome (DHS).MethodsFrom May 2020 to January 2021, CRC patients d
Externí odkaz:
https://doaj.org/article/bd8bc3eb1e874155acf2551b5d459cdb
Autor:
Chong-De Lu, Ya-Bo Jiang, Jin-Kai Feng, Lei Wang, Xu-Biao Wei, Bin Zhou, Xiao-Lu Lin, Wei-Xing Guo, Wan Yee Lau, Shu-Qun Cheng
Publikováno v:
Heliyon, Vol 9, Iss 9, Pp e20015- (2023)
Purpose: To compare the survival outcomes of postoperative adjuvant aspirin with surgery alone in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT). Methods: From June 2013 to July 2015
Externí odkaz:
https://doaj.org/article/e71065806bc34c64a1e44787b33d9c53
Autor:
Yu-Qing Zhang, Kang Wang, Jin-Kai Feng, Lu-Yun Yuan, Chao Liang, Yan-Jun Xiang, Xu Wang, Fei-Fei Mao, Shu-Qun Cheng
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundImmune checkpoint inhibitor (ICI), coupled with systemic chemotherapy, may enhance the clinical benefit of cancer by potentiating antitumor immunity, but its efficacy and safety are not clear in advanced intrahepatic cholangiocarcinoma (ICC
Externí odkaz:
https://doaj.org/article/20b04a6fc4454921a38cfb6e07a02fb1
Autor:
Fei-Fei Mao, Shan-Shan Gao, Yan-Jie Huang, Nian Zhou, Jin-Kai Feng, Zong-Han Liu, Yu-Qing Zhang, Lu-Yun Yuan, Gang Wei, Shu-Qun Cheng
Publikováno v:
Frontiers in Nutrition, Vol 10 (2023)
BackgroundGanoderma lucidum is reportedly the best source of traditional natural bioactive constituents. Ganoderma triterpenoids (GTs) have been verified as an alternative adjuvant for treating leukemia, cancer, hepatitis and diabetes. One of the maj
Externí odkaz:
https://doaj.org/article/1792b8a7e4d24aa4b1a6dfe88150a9f0